1100 13th Street, NW, Suite 750Washington, DC 20005202.887.6400Toll-free: 800.544.0155
All Contents © 2017The Kiplinger Washington Editors
The little-known money manager’s existing funds, which are now closed to investors, have clobbered their benchmarks.
Our picks should deliver solid long-term gains with less drama than the racy tech and biotech stocks strutting in the limelight.
We name 11 companies that tick off customers but are worth adding to your portfolio.
More Investing News »